Navigation Links
Abbott Receives FDA Approval for TRILIPIX(TM) (fenofibric acid), First and Only Fibrate Indicated for Use in Combination With a Statin for Cholesterol Management
Date:12/15/2008

ell as more aggressive management of HDL and triglycerides.

About the TRILIPIX Clinical Trial Program

The FDA's approval of TRILIPIX was based on the largest clinical trial program to date designed to evaluate the efficacy and safety of a fibrate in combination with various statins. The efficacy and safety of TRILIPIX in combination with the three most commonly prescribed statins -- rosuvastatin, atorvastatin and simvastatin -- was evaluated in three randomized, multicenter, double-blind, controlled, 12-week Phase III studies, totaling 2,698 patients with mixed dyslipidemia. Patients included in the studies had multiple lipid problems, with an LDL > 130 mg/dL, triglycerides > 150 mg/dL and HDL less than 40 mg/dL for men and less than 50 mg/dL for women. A total of 1,911 patients who completed one of the 12-week studies subsequently enrolled in a 52-week long-term, open-label extension study.

The Phase III combination studies all met their primary endpoints. Combination therapy significantly improved HDL and triglycerides compared to statin therapy alone, and significantly improved LDL compared to TRILIPIX alone. All of the combinations and the statins had clinically meaningful reductions in LDL.

"Physicians told us that they needed data supporting the use of a fibrate with statins to help them more aggressively manage their patients' lipid problems," said Eugene Sun, M.D., vice president, Global Pharmaceutical Clinical Development, Abbott. "Abbott built a robust clinical program to support the use of TRILIPIX, and its approval adds a new option to Abbott's growing dyslipidemia portfolio which provides treatments to comprehensively help address all three key lipids."

Abbott and AstraZeneca are working together to develop a fixed-dose combination of Abbott's TRILIPIX and AstraZeneca's CRESTOR(R) (rosuvastatin calcium) with plans to submit a new drug application to t
'/>"/>

SOURCE Abbott
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Abbott to Present at Bear Stearns Healthcare Conference
2. The National Center for Missing & Exploited Children, Wal-Mart, and Abbott Host Child Safety Events
3. Dow Jones Sustainability Index Again Recognizes Abbott for Continued Leadership in Business, Environmental and Social Performance
4. Abbott Declares 335th Consecutive Quarterly Dividend
5. Abbott Again Honored as Top Company for Working Moms
6. Abbotts HUMIRA(R) (adalimumab) Honored With Prestigious Galen Prize for Innovation in Patient Care
7. Abbott Hosts Conference Call for Third-Quarter Earnings
8. Abbott Broadens Use of i-STAT Handheld Blood Analyzer with CLIA Waiver Granted by FDA for CHEM8+ Test Cartridge
9. Abbott Named One of the Best Companies for Hispanics by Hispanic Business Magazine
10. Abbott Again Honored as a Leader in Diversity
11. Abbott Researchers Target Neuronal Nicotinic Receptors for Treatment of Pain and Cognition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/1/2014)... Insuranceragents.info has released a new blog post ... for vulnerable family members. , Life insurance plans provide ... the family should always carry a life insurance policy ... rest of the family. , Clients can choose ... from temporary coverage or from a permanent policy. No ...
(Date:10/1/2014)... and ATLANTA (PRWEB) October 01, 2014 ... security executive networking and relationship-marketing firm, announced ... Information Security Executive® and Project of the ... top-ranking decision makers representing organizations in financial ... Projects include large-scale technology endeavors that address ...
(Date:10/1/2014)... (PRWEB) October 01, 2014 Between 23 ... in the U.S., according to figures from the National ... Diseases Association (AARDA), and many of them have something ... of having undiagnosed celiac disease. Gluten Free Therapeutics, ... awareness of undiagnosed celiac disease by publishing a series ...
(Date:10/1/2014)... 01, 2014 Scientists at the University ... that target immune system proteins has the power to ... posted details of the new study on their website. ... , Researchers in the UWA School of Pathology and ... to mice with mesothelioma with promising results. , ...
(Date:10/1/2014)... 01, 2014 Woodland Hills dental ... a group of dental specialists who treat full mouth ... city of Oviedo. Dr. Reshad of the Anacapa Dental ... clients on two continents, will give a full-day presentation ... mouth reconstruction. , “These specialists want to improve their ...
Breaking Medicine News(10 mins):Health News:Life Insurance for Families - Clients Can Compare Affordable Rates Online! 2Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 2Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 3Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 4Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 5Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 6Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 7Health News:Informative New Blog Series Underscores Link Between Celiac Disease and Other Autoimmune Disorders 2Health News:Informative New Blog Series Underscores Link Between Celiac Disease and Other Autoimmune Disorders 3Health News:New Mesothelioma Study Says Mice Cured by Immuntherapy “Cocktail”, Reports Surviving Mesothelioma 2Health News:Woodland Hills Dental Implants Expert Training Dental Specialists in Spain Later This Week 2Health News:Woodland Hills Dental Implants Expert Training Dental Specialists in Spain Later This Week 3Health News:Woodland Hills Dental Implants Expert Training Dental Specialists in Spain Later This Week 4
... that often deals with changes over many generations have ... A lot, some scientists say. If recent recommendations are implemented, ... entrance and licensing exams, says an international group of doctors ... 26 issue of Proceedings of the National Academy of ...
... is the focus of a $1.27-million grant from the ... researchers working with employees from six Pennsylvania prisons and ... an intervention toolkit for use by staff at any ... to optimize the quality of life for dying patients ...
... Vancouver’s ... meet Matt Lauer when he is in Vancouver to shoot the Today Show during the ... (PRWEB) ... is on a mission to meet Matt Lauer when he is in Vancouver to shoot ...
... , ... Spend More Time Indoors Increasing Owners Exposure to Allergens Like Pet Dander. earthbath’s Totally Natural ... , ... 26, 2010 -- Everyone wants to be inside when winter’s chilly winds blow, and Fido ...
... ... for physicians, including current and future adoption of electronic medical records, e-prescribing, ... ... are the physician specialist groups most likely to communicate with patients online, according ...
... SEATTLE , Jan. 26 Milliman Care Guidelines ... tools that help health plans, hospitals and other clients optimize ... and software.   , The Care Guidelines promote ... based on annually updated evidence, thus enabling informed and consistent ...
Cached Medicine News:Health News:Medical students may soon be tested on evolution 2Health News:Medical students may soon be tested on evolution 3Health News:End-of-life care strategies examined in Pennsylvania prisons 2Health News:Vancouver Company Must Meet Matt Lauer During Olympics 2Health News:Control Winter Pet Dander with earthbath's New Waterless Grooming Foam for Dogs 2Health News:Control Winter Pet Dander with earthbath's New Waterless Grooming Foam for Dogs 3Health News:Dermatologists, Medical Oncologists are the Top Physician Specialist Groups Communicating with Patients Online 2Health News:Dermatologists, Medical Oncologists are the Top Physician Specialist Groups Communicating with Patients Online 3Health News:Dermatologists, Medical Oncologists are the Top Physician Specialist Groups Communicating with Patients Online 4Health News:Milliman Care Guidelines Offers Online Interrater Reliability Tool and Training 2Health News:Milliman Care Guidelines Offers Online Interrater Reliability Tool and Training 3Health News:Milliman Care Guidelines Offers Online Interrater Reliability Tool and Training 4
(Date:10/1/2014)... , Oct. 1, 2014  SI-BONE, Inc., a medical ... System, ® a minimally invasive surgical (MIS) device indicated ... today announced the expansion of its European operations with the ... Eric Schaber as General Manager, Germany.  Mr. Schaber will ... president of Europe , Middle ...
(Date:9/30/2014)... 30, 2014 /CNW/ - Protecting the health and safety of Canadians ... uses the appropriate powers and tools at its disposal to help ... quality standards. To that end, Health ... import into Canada of all drug products ... are: , Apotex Pharmachem India Pvt Ltd ...
(Date:9/30/2014)... Md. , Sept. 30, 2014  Tasly ... way to modernize medicine, announced today the launch ... of nutraceuticals developed to address men and women ... healthy and vibrant into old age while helping ... includes three condition-specific, whole-food and herb-based formulas, namely, ...
Breaking Medicine Technology:SI-BONE, Inc. Announces European Expansion with Appointment of Eric Schaber as General Manager, Germany and Formation of GmbH 2SI-BONE, Inc. Announces European Expansion with Appointment of Eric Schaber as General Manager, Germany and Formation of GmbH 3SI-BONE, Inc. Announces European Expansion with Appointment of Eric Schaber as General Manager, Germany and Formation of GmbH 4Statement by the Honourable Rona Ambrose on the import ban of drug products from three plants in India 2
... 17 An optimized PARI eFlow,platform nebulizer will ... clinical trial that has begun enrolling patients. ALN-RSV01 ... for respiratory syncytial virus,(RSV) infection, the leading cause ... infection in immune-compromised adults. RSV currently does,not have ...
... 17 AlphaVax, Inc.,announced today an initial analysis ... a cytomegalovirus (CMV) vaccine that is based on ... is a placebo-controlled, randomized, double-blind, single,center study involving ... is being conducted by David I. Bernstein, M.D., ...
Cached Medicine Technology:PARI's eFlow Delivers Alnylam RNAi Therapeutic in Phase II Study 2AlphaVax Announces Initial Analysis of Data From CMV Phase 1 Clinical Trial 2AlphaVax Announces Initial Analysis of Data From CMV Phase 1 Clinical Trial 3
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: